1. Panel Discussant: “The Role of Intellectual Property in Global Development,” World Intellectual Property Day Event, sponsored by the Institute for Policy Innovation (IPI), Washington, DC, April 26, 2006.
2. Presentation: “Counterfeiting and Piracy Issues Facing the US Pharmaceutical Industry,” Academy on the Enforcement of Intellectual Property Rights, US Patent and Trademark Office, Alexandria, VA, August 11, 2005.
3. Presentation: “Intellectual Property Protection,” Training Program on Commercial Tradecraft for State Department Commercial Officers, Business Council for International Understanding, Washington, DC, August 9, 2005.
4. Presentation: “Intellectual Property Issues Facing the Pharmaceutical Industry,” Protecting Intellectual Property Rights in the Global Marketplace, US State Department Program for Latin American Intellectual Property Specialists, Washington, DC, June 16, 2005.
5. Presentation: “A Historical Perspective on Data Exclusivity,” International Workshop on Data Exclusivity (supported by MOFCOM WTO Affairs Department and sponsored by RDPAC and CAEFI), Beijing, China, February 28, 2005.
Beijing, China
6. Presentation: “Intellectual Property in US Trade Agreements,” Seminar on Intellectual Property Rights: A Look at Trade Agreements, Implementation and Healthcare in the Americas, Business Council for International Understanding, Washington, DC, July 19, 2004.
7. Presentation: “Punta del Este to Cancun: TRIPS from Concept to Practice,” Conference on the New Intellectual Property Order: A Global Trade Off, Sponsored by the University of Haifa Faculty of Law and the Inter Disciplinary Center, Herzliya, Israel, June 13-14, 2004.
8. Presentation: “Capacity Building for Innovation: Institutional Linkages and Policy Framework,’” ICC-India, FICCI, IIPD International Conference on Intellectual Property Policy: Research and Innovation in Developing Countries,” New Delhi, India, March 16-17, 2004.
9. Presentation: “TRIPs, Doha, Cancun and Access to Medicines,” Meeting of the General Counsels’ Committee, BIO (Biotechnology Industry Association), Boston, MA, October 20, 2003.
10. Keynote Speaker: “Data Exclusivity and R&D Perspectives for India,” R&D and Data Exclusivity Roundtables” (jointly sponsored by the Associated Chambers of Commerce of India, the Organisation of Pharmaceutical Producers of India, and Crop Life India), Mumbai and New Delhi, India, April 29-30, 2003.
11. Participant: Fourth Informal Consultation between Civil Society Organizations and the OECD Trade Committee, Paris, France, October 28, 2002.
12. Presentation: “Encouraging Innovation,” 21st Assembly of the International Federation of Pharmaceutical Manufacturers Associations (IFPMA), Berlin, Germany, October 1, 2002.
13. Presentation: “Protection of Undisclosed Information through Data Exclusivity Legislation: A Cross-Country Analysis,” Rajiv Gandhi Institute for Contemporary Studies, Rajiv Gandhi Foundation, New Delhi, India, August 29, 2002.
14. Presentation: “Protection of Undisclosed Information through Data Exclusivity Legislation: A Cross-Country Analysis,” Institute of Intellectual Property Development, FICCI, New Delhi, India, August 28, 2002.
15. On-air Interview (Television) on Data Exclusivity in India: Star Business News, New Delhi, India, August 27, 2002.
16. Presentation: “WTO, TRIPs and the Indian Patent Act,” The Indo-American Chamber of Commerce, New Delhi, India, August 27, 2002.
17. Moderator: Panel on The Next Challenges for Intellectual Property, 34th World Congress of the International Chamber of Commerce, Denver, CO, May 7, 2002.
18. Luncheon Speaker: “An Industry Perspective on the TRIPs Agreement,” International Trade Seminar on Legal Aspects of International Trade: Session III (TRIPs), Jointly Sponsored by the World Bank Legal Vice Presidency, World Trade Organization and World Bank Institute, Washington, DC, March 25, 2002.
19. Speaker: “Intellectual Property Issues,” Obvious Doesn’t Mean Easy: Colloquium on Completing the Chile – USA FTA, The Global Business Dialogue, Washington, DC, March 7, 2002.
20. Presentation: “Data Exclusivity in the Pharmaceutical Industry,” Conference on the Importance of Data Exclusivity in the Globalizing Economy, The National Policy Research Foundation, Ankara, Turkey, January 31, 2002.
21. Presentation: “Preparing for the Free Trade Area of the Americas (FTAA) and Effective Product Registration Strategies Update,” Fifth Annual Conference on Clinical and Regulatory Strategies for Latin America, Philadelphia, PA, January 10, 2002.
22. Presentation: “Intellectual Property Rights and Doha,” Global Business Dialogue Conference on the WTO: Anticipating Qatar and the Fourth WTO Ministerial Meeting, Washington, DC, June 19, 2001.
New Delhi, India
23. Presentation: “Current and Future Environment for Intellectual Property: Problems and Opportunities,” INTERPAT, Washington, DC, May 7, 2001.
24. Speaker: “US Industries, Trade Associations and Intellectual Property Lawmaking,” Symposium on World Trade, Intellectual Property and the Global Elites: International Lawmaking in the New Millennium, Cardozo School of Law of Yeshiva University, New York, NY, March 7, 2001.
25. Presentation: “Protecting Intellectual Property – Recent Regulatory Initiatives,” Conference on Innovative Regulatory and Clinical Strategies in Latin America, Washington, DC, January 25, 2001.
26. Presentation: “How Can Industry Address the Myths about the Relationship Between Intellectual Property Rights and Access?,” 20th Assembly of the International Federation of Pharmaceutical Manufacturers Associations (IFPMA), Geneva, Switzerland, November 14, 2000.
27. Presentation: “The Status and Future of Intellectual Property: Challenges and Opportunities,” INTERPAT, Newark, NJ, November 6, 2000.
28. Principal presenter: Training Program on Intellectual Property Rights in the Asia Pacific Region, 13th Asia Managers Conference and Seminar, Pharmaceutical Research and Manufacturers of America (PhRMA), Hong Kong, S.A.R., October 30, 2000.
29. Presentation: “Protection of Proprietary Data Abroad: TRIPS and Other Creative Enforcement Measures,” Joint Meeting of the Trade Secret and the International Criminal Law and National Security Law Committees, International Law Section, District of Columbia Bar, July 10, 2000.
30. Presentation: “Safeguard Against Intellectual Property Violations – Can it be Done in Latin America?” Second Annual Conference on Latin American Bio/ Pharmaceuticals, Miami Beach, Florida, March 27, 2000.
31. Commenter: “Panel on Review of Key Substantive Uruguay Round Agreements: the TRIPS Agreement,” Symposium on the First Five Years of the WTO, ABA Section of International Law and Practice, Washington, DC, January 21, 2000.
32. Roundtable Participant: “Intellectual Property Protection for Pharmaceuticals: Emerging Issues in the Global Economy,” The Pfizer Journal, Global Edition Volume 1, Number 2 (2000)
33. Principal Presenter: Intellectual Property Rights Training Program for Leadership of Local Area Working Groups in the Middle East and Africa, Pharmaceutical Research and Manufacturers of America (PhRMA), Paris, France, December 13 - 14, 1999.
34. Principal Presenter: Conference on Intellectual Property Rights and Pharmaceuticals, Organized by the US Embassy Budapest, US Commercial Service and the Pharmaceutical Research and Manufacturers of America, International Law Enforcement Academy, Budapest, Hungary, November 9 – 10, 1999.
35. Presentation: “The Uruguay Round in Practice: Implementing Existing Agreements: The TRIPs Agreement,” Conference on the WTO and the Seattle Ministerial, US Chamber of Commerce, Washington, DC, October 14, 1999.
36. Principal Presenter: Intellectual Property Rights Training Program for Leadership of Local Area Working Groups in Central and Eastern Europe, Pharmaceutical Research and Manufacturers of America (PhRMA), Vienna, Austria, September 28, 1999.
Geneva, Switzerland
37. Presentation: “Patent Standards: Lessons from Commercial Experience in the United States and the EU,” Panel on Extending TRIPs: Pharmaceutical and Biotechnological Product Protection, Financial Times Conference on Intellectual Property and Global Trade: TRIPs and a New WTO Round, London, United Kingdom, September 30, 1999.
38. Presentation: “Intellectual Property Protection in Latin America,” Conference on Clinical and Regulatory Strategies for the Emerging Pharmaceutical Market in Latin America, Philadelphia, PA, September 23, 1999.
39. Presentation: “Treatment of Intellectual Property at the Seattle Ministerial,” Trade Policy Series, Washington International Trade Association, Washington, DC, August 4, 1999
40. Presentation: “Intellectual Property Rights and Piracy,” Panel on High Technology/Telecommunications Sector, Investing in the Middle East: New Opportunities in a Changing Global Economy, Conference organized by the Council on Foreign Relations, New York, NY, June 18, 1999.
41. Presentation: “Intellectual Property Protection in Lithuania: The TRIPS Agreement and WTO Accession,” Workshop sponsored by the US Embassy, Vilnius, Lithuania, June 8, 1999.
42. Presentation: “The Role of Data and Intellectual Property Protection,” Orientation Visit for Officials of Central and Eastern Europe sponsored by the U.S. Trade and Development Agency in partnership with the Pharmaceutical Research and Manufacturers of America, Washington, DC, April 12, 1999.
43. Principal presenter: Intellectual Property Rights Training Program for Leadership of Local Area Working Groups in Latin America, Pharmaceutical Research and Manufacturers of America (PhRMA), Boca Raton, Florida, March 22-23, 1999.
44. Presentation: “Intellectual Property Protection in Latin America,” Conference on Clinical and Regulatory Strategies for the Emerging Pharmaceutical Market in Latin America, Miami Beach, FL, November 12, 1998.
45. Moderator, “Intellectual Property Issues Panel,” Ripon Transatlantic Conference, Madrid, Spain, November 11, 1998.
46. Presentation: “International Intellectual Property Issues with a Special Emphasis on Pharmaceuticals,” Seminar for Judges from the Russian Federation on Protection of Intellectual Property Issues, Federal Judicial Center, Washington, DC, September 24, 1998.
47. Presentation: “Importance of Patent and Trade Secret Protection,” Panel on Intellectual Property Rights, Political and Economic Tradecraft Course, Foreign Service Institute, US Department of State, Arlington, Virginia, 1998 - 2001 (annual)
48. Presentation: “Pharmaceutical Patent Protection: The View from the United States,” Conference on Technology Commercialization: Managing Intellectual Property for Maximum Profit, United States – Israel Science and Technology Commission, Tel Aviv, Israel, March 22, 1998.
49. Presentation: “The WTO TRIPS Agreement: Key Obligations on Patents and Data Exclusivity,” Conference on Technology Commercialization: Managing Intellectual Property for Maximum Profit, United States – Israel Science and Technology Commission, Tel Aviv, Israel, March 22, 1998.
50. Appearance: Moderator of Panel on Implementation of TRIPS Patent Provisions, US - EU Symposium on Intellectual Property, TransAtlantic Business Dialogue, Washington, DC, October 7, 1997.
51. Presentation: “Patent Protection and Economic Development,” Series of Seminars for Members of the Indian Scientific and Research Community in New Delhi, Hyderabad and Calcutta, India, September 10 - 19, 1997.
52. Presentation: “U.S. Trade Policy and Intellectual Property,” Annual Meeting of the Drug Information Association, Montreal, Canada, June 26, 1997.
53. Presentation: “Intellectual Property,” International Trade Agreements and Transactions Seminar, International Law Institute, Washington, DC, May 13, 1997.
54. Presentation: “Intellectual Property Protection,” Training Program for State Department Commercial Officers and Deputy Chiefs of Mission, Business Council for International Understanding, Washington, DC, 1995-1998 (annual).
55. Presentation: “Future Perspectives on Intellectual Property,” Panel on Intellectual Property, Textiles and Tariffs, Conference on the Future Shape of International Trade, Overseas Development Council, Washington, DC, November 21, 1996.
56. Appearance: “Views of the IPC on the WTO Singapore Ministerial Meeting,” Hearings of the Ways and Means Subcommittee on Trade, U.S. House of Representatives, September 11, 1996.
57. Presentation: “The Economic Importance of Copyright,” Seminar on Current Issues of Copyright and Neighboring Rights for C.I.S. Countries Jointly Sponsored by the U.S. Copyright Office and the World Intellectual Property Organization, Washington, DC, June 24, 1996.
58. Presentation: “EU and US Cooperation in Support of Third Country Implementation of the TRIPS Agreement,” Transatlantic Workshop on Intellectual Property Rights in the Framework of the Joint EU-US Action Plan, Rome, Italy, May, 28, 1996.
59. Presentation: “TRIPS and the INTERPAT Negotiating History Project,” 1996 INTERPAT Meeting, London, England, May 21, 1996.
60. Presentation: “Legislative Reform Efforts,” Medical Marketing and Intellectual Property Rights Meetings, Pfizer Inc, London, England, May 2, 1996.
61. Presentation: “Overview of Patent Protection for Pharmaceutical Products,” President’s Council Seminar on Patent Rights, Cairo, Egypt, April 16, 1996.
62. Presentation: “International Intellectual Property Protection under a WTO/TRIPS Regime: Patents,” Fourth Annual Conference on International Intellectual Property Law and Policy, Fordham University School of Law, New York, NY, April 12, 1996.
63. Presentation: “Patent Protection and Economic Development,” Seminar on Patents and Global Economics, Sao Paulo, Brazil, May, 8, 1995.
64. Appearance: “The Changing International Legal and Institutional Environment for Intellectual Property,” Symposium on The International Relations of Intellectual Property: Challenges at the Turn of the Century, Global Intellectual Property Project of The American University, Washington, DC, April 25, 1995.
65. Presentation: “The Benefits for Egypt of Immediate Patent Protection for Pharmaceutical Products,” Alexandria Pharmaceutical Association, Alexandria, Egypt, March 22, 1995.
66. Presentation: “International Patent Effects of GATT,” New Jersey Intellectual Property Law Association, Summit, NJ, March 9, 1995.
67. On-air Interview concerning Intellectual Property Rights, Dow Jones Investor Network, Live (Washington), December 14, 1994.
68. Speech: “Intellectual Property Protection: NAFTA, GATT and WIPO,” Meeting of Intellectual Property Committee, Aerospace Industries Association, Arlington, VA, April 20, 1994.
69. Appearance: “IPC Views on the WTO TRIPS Agreement,” Hearings of the House Foreign Affairs Subcommittee on Economic Policy, Trade and Environment, March 8, 1994.
70. Presentation: “Patent Protection Under the GATT Umbrella,” Forum of the International Federation of Intellectual Property Attorneys (FICPI), Rome, Italy, November 12, 1993.
71. Speech: “The Effect of NAFTA on the Pharmaceutical Industry,” Strategic Planning Conference, Burroughs-Wellcome Co., Montreal, Canada, June 22, 1993.
72. Presentation: “An International Review,” World Symposium on Intellectual Property Rights, New Delhi, India, February 9, 1993.
73. Speech: “Intellectual Property Protection and U.S. Investment Decisions,” Lexpo ‘93: Legal and Financial Aspects of Doing Business in India and the U.S., New Delhi, India, 1993.
74. Presentation: “Elements of Strong Patent Protection for Pharmaceutical Products,” Turkish Patent Conference, Ankara, Turkey, August 26, 1992.
75. Presentation: “Patent Protection for Pharmaceutical and Chemical Products,” Seminar on China - U.S. Intellectual Property Management, Beijing, China, May 19-22, 1992.
76. Speech: “GATT and Intellectual Property,” Honeywell Symposium on Intellectual Property, Washington, DC, March 11, 1991.
77. Presentation: “The GATT TRIPS Negotiations: A Private Sector Assessment,” Intellectual Property Meeting, Alcan International Limited, Val Morin, Canada, June 13, 1989.
78. Presentation: “GATT - A View from the United States,” Sixty-second Annual General Meeting, Patent and Trademark Institute of Canada, St. Jovite, Quebec, September 30, 1988.
79. Presentation: “Intellectual Property Issues in International Communication,” Faculty Seminar on International Communication, George Washington University / Broadcast Education Association, Washington, DC, October 30, 1987.
80. Presentation: “The U.S. Industry Perspective on the Intellectual Property Initiative in the GATT,” 18th International Congress, Pacific Intellectual Property Association, Baltimore, MD, September 30, 1987.
81. Appearance as guest expert on intellectual property issues, All Things Considered, National Public Radio, May 6, 1986.
82. Speech: “Financing Israel - U.S. Trade and Growth of Israeli Industry,” Conference on U.S. Government Procurement and General Trade Opportunities, Sponsored by the Government of Israel Ministry of Defense and the Manufacturers’ Association of Israel, Tel Aviv, Israel, October, 1984.